Bicocca Open Archive

Logo unimib boa
CHINELLO, CLIZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.531
EU - Europa 6.093
AS - Asia 2.604
SA - Sud America 202
AF - Africa 24
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 11
Totale 18.476
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.350
IT - Italia 1.570
SG - Singapore 1.034
DE - Germania 977
RU - Federazione Russa 812
CN - Cina 802
IE - Irlanda 728
SE - Svezia 677
HK - Hong Kong 373
GB - Regno Unito 278
AT - Austria 261
UA - Ucraina 241
BR - Brasile 173
CA - Canada 170
FR - Francia 118
FI - Finlandia 101
VN - Vietnam 89
DK - Danimarca 84
ID - Indonesia 73
IN - India 64
NL - Olanda 64
BE - Belgio 45
TR - Turchia 29
PL - Polonia 28
ES - Italia 21
JP - Giappone 21
CZ - Repubblica Ceca 18
IR - Iran 18
KR - Corea 17
RO - Romania 14
CH - Svizzera 13
TW - Taiwan 12
IL - Israele 11
AU - Australia 10
EU - Europa 10
PH - Filippine 9
UZ - Uzbekistan 7
ZA - Sudafrica 7
GR - Grecia 6
MA - Marocco 6
PK - Pakistan 6
TH - Thailandia 6
BG - Bulgaria 5
EC - Ecuador 5
LV - Lettonia 5
MY - Malesia 5
NO - Norvegia 5
AE - Emirati Arabi Uniti 4
AR - Argentina 4
AZ - Azerbaigian 4
CL - Cile 4
HR - Croazia 4
KG - Kirghizistan 4
LT - Lituania 4
PA - Panama 4
PE - Perù 4
SA - Arabia Saudita 4
VE - Venezuela 4
BO - Bolivia 3
CO - Colombia 3
LU - Lussemburgo 3
MX - Messico 3
AL - Albania 2
BD - Bangladesh 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BT - Bhutan 1
CI - Costa d'Avorio 1
EE - Estonia 1
HU - Ungheria 1
IM - Isola di Man 1
IQ - Iraq 1
JO - Giordania 1
KE - Kenya 1
LK - Sri Lanka 1
MT - Malta 1
MU - Mauritius 1
MZ - Mozambico 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PY - Paraguay 1
SC - Seychelles 1
TG - Togo 1
UY - Uruguay 1
VG - Isole Vergini Britanniche 1
Totale 18.476
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.127
Fairfield 773
Chandler 722
Dublin 719
Singapore 714
Milan 640
Woodbridge 626
Frankfurt am Main 606
Wilmington 530
Ashburn 526
Houston 506
Hong Kong 368
Dearborn 358
Seattle 312
Santa Clara 278
New York 250
Cambridge 244
Vienna 237
Jacksonville 233
Princeton 175
Shanghai 170
Nanjing 135
Jakarta 66
Beijing 63
Lawrence 63
Altamura 62
Los Angeles 61
Fremont 59
Nanchang 56
Helsinki 51
Guangzhou 49
Dong Ket 48
Council Bluffs 47
Moscow 43
Brussels 42
Lachine 40
San Diego 39
Montréal 38
Ottawa 38
Toronto 34
Shenyang 29
Lissone 27
Nuremberg 27
Chicago 26
London 26
Andover 25
Hebei 23
Düsseldorf 22
Munich 22
Changsha 20
Florence 20
Tianjin 20
Zhengzhou 20
Caronno Pertusella 19
Falls Church 19
Kunming 19
Pune 19
Rome 19
Boardman 18
Jiaxing 18
Jinan 18
Cinisello Balsamo 17
Brescia 16
Madison 16
Ningbo 16
Norwalk 16
Pavia 15
Como 14
Edmonton 14
Brno 13
Genoa 13
Kiev 13
Ripalta Cremasca 13
São Paulo 13
Romola 12
Washington 12
Dallas 11
Hangzhou 11
Melzo 11
Turin 11
Bonndorf 10
Mountain View 10
Seregno 10
Monza 9
Padova 9
Taizhou 9
Verona 9
Bergamo 8
Cagliari 8
Carate Brianza 8
Huizen 8
Lauterbourg 8
Napoli 8
Terni 8
Amsterdam 7
Coventry 7
Kilburn 7
Lille 7
Messina 7
Minamikasugaoka 7
Totale 13.025
Salva come PNG Salva come JPEG
Nome #
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging 443
Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma 387
Comparative membrane proteomics: A technical advancement in the search of renal cell carcinoma biomarkers 377
Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier 362
Differential protein profiling of renal cell carcinoma urinary exosomes 342
Urinary exosomes and diabetic nephropathy: a proteomic approach 318
Effects of Hematuria on the Proteomic Profile of Urinary Extracellular Vesicles: Technical Challenges 293
Feasibility Study for the MALDI-MSI Analysis of Thyroid Fine Needle Aspiration Biopsies: Evaluating the Morphological and Proteomic Stability Over Time 293
A novel versatile precursor suitable for 18F-radiolabeling via “click chemistry” 289
Antigen Retrieval and Its Effect on the MALDI-MSI of Lipids in Formalin-Fixed Paraffin-Embedded Tissue 285
In-Depth mapping of the urinary N-glycoproteome: Distinct signatures of ccRCC-related progression 284
Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades 283
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine 283
Serum biomarkers of Renal Cell Carcinoma assessed using a protein profiling approach based on ClinProt technique 271
The proteomic landscape of renal tumors 267
ETNK1 mutations in atypical chronic myeloid leukemia induce a mutator phenotype that can be reverted with phosphoethanolamine 265
Proteomic profiles of thyroid tumors by Mass Spectrometry-Imaging on Tissue Microarrays 252
The management of haemoglobin interference for the MALDI-MSI proteomics analysis of thyroid fine needle aspiration biopsies 252
The putative role of MALDI-MSI in the study of Membranous Nephropathy 251
TdT expression in germ cell tumours: a possible immunohistochemical cross-reaction and diagnostic pitfall 248
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 245
Histoproteomic characterization of localized cutaneous amyloidosis in X-linked reticulate pigmentary disorder 244
Detecting Proteomic Indicators to Distinguish Diabetic Nephropathy from Hypertensive Nephrosclerosis by Integrating Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging with High-Mass Accuracy Mass Spectrometry 244
Characterization of prion protein-enriched domains, isolated from rat cerebellar granule cells in culture 241
Robust conclusions in mass spectrometry analysis 239
Mutual Information Optimization for Mass Spectra Data Alignment 236
Functional heterogeneity of lymphocytic patterns in primary melanoma dissected through single-cell multiplexing 235
A MALDI-Mass Spectrometry Imaging method applicable to different formalin-fixed paraffin-embedded human tissues 233
Urinary extracellular vesicles and salt-losing tubulopathies: A proteomic approach 230
Different expression of Fibrinopeptide A and related fragments in serum of type 1 diabetic patients with nephropathy 224
Primary cell cultures from human renal cortex and renal-cell carcinoma evidence a differential expression of two spliced isoforms of Annexin A3 215
Alterations of the serum peptidome in renal cell carcinoma discriminating benign and malignant kidney tumors 214
Tumor size, stage and grade alterations of urinary peptidome in RCC 213
Urinary Peptidome and Proteome Alterations Related to Tumor Progression and Invasion in RCC 212
Proteome analysis in thyroid pathology 209
Urinary Signatures of Renal Cell Carcinoma Investigated by Peptidomic Approaches 209
Advances in membranous vesicle and exosome proteomics improving biological understanding and biomarker discovery 208
Protein profiling of microdomains purified from renal cell carcinoma and normal kidney tissue samples 205
Analysis of correlation structures in renal cell carcinoma patient data 200
Aberrant N-glycosylation patterns related to serum IgG subclasses in Idiopathic membranous nephropathy 200
Human urine biomarkers of renal cell carcinoma evaluated by ClinProt 195
An Alternative Approach in Endocrine Pathology Research: MALDI-IMS in Papillary Thyroid Carcinoma 195
Proteomics in thyroid cytopathology: Relevance of MALDI-imaging in distinguishing malignant from benign lesions 193
Imaging mass spectrometry: a new tool for kidney disease investigations 184
Proteomic analysis in clear cell renal cell carcinoma: identification of differentially expressed protein by 2-D DIGE 180
Erratum: Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section (Journal of Proteome Research (2022) 21: 11 (2798−2809) DOI: 10.1021/acs.jproteome.2c00601) 178
Spatial lipidomics of tumour-infiltrating lymphocytes for the typing of colorectal cancer by MALDI mass spectrometry imaging 177
The urinary proteome and peptidome of renal cell carcinoma patients: A comparison of different techniques 175
A Mutual Information Approach to Data Integration for Alzheimer’s Disease Patients 173
Intraluminal proteome and peptidome of human urinary extracellular vesicles 173
A molecular imaging approach to individuate tumour infiltrating lymphocytes 173
Non-invasively collected amniotic fluid as a source of possible biomarkers for premature rupture of membranes investigated by proteomic approach 172
A Support Vector Machine Classification of Thyroid Bioptic Specimens Using MALDI-MSI Data 171
Novel frontiers in diagnostic pathology: MALDI-MSI of thyroid fine needle aspiration biopsies 165
Towards the standardization of mitochondrial proteomics: the Italian mt-HPP initiative 164
Downregulation of C3 and C4A/B complement factor fragments in plasma from patients with squamous cell carcinoma of the penis 163
3D gelatin-chitosan hybrid hydrogels combined with human platelet lysate highly support human mesenchymal stem cell proliferation and osteogenic differentiation 163
Lipidomic typing of colorectal cancer tissue containing tumour-infiltrating lymphocytes by MALDI mass spectrometry imaging 161
Detection of high molecular weight proteins by MALDI imaging mass spectrometry 160
AQP1 expression analysis in human diseases: Implications for proteomic characterization 158
Modulation of urinary peptidome in humans exposed to high altitude hypoxia 156
Untargeted Mass Spectrometry Approach to Study SARS-CoV-2 Proteins in Human Plasma and Saliva Proteome 146
Advances in clinical proteomics for analysis of fine needle aspiration biopsies: evaluating proteomics stability in preservative solutions 146
Proteomics imaging and the kidney 144
Synthesis and automated fluorine-18 radiolabeling of new PSMA-617 derivatives with a CuAAC radiosynthetic approach 143
Proteomics and glomerulonephritis: A complementary approach in renal pathology for the identification of chronic kidney disease related markers 142
Progress in clinical applications for the proteomics MALDI Imaging analysis of thyroid fine needle aspiration biopsies 140
Proteomic and bioinformatic studies for the characterization of response to pemetrexed in platinum drug resistant ovarian cancer 139
Definition of IgG Subclass-Specific Glycopatterns in Idiopathic Membranous Nephropathy: Aberrant IgG Glycoforms in Blood 138
Immunoreattività e carcinoma renale 133
Characterization of distinguishing regions for Renal Cell Carcinoma discrimination 133
Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia 131
The evolving landscape of diagnostic pathology: a step towards the integration of MALDI-MSI for the routine diagnosis of thyroid fine needle aspiration biopsies 127
Biomarkers discovery by peptide and protein profiling in biological fluids based on functionalized magnetic beads purification and mass spectrometry 124
Progress in clinical applications for the MALDI-imaging analysis of thyroid fine needle aspiration biopsies: evaluation of proteomic stability in preservative solutions 118
Proteomic Fingerprint of Lung Fibrosis Progression and Response to Therapy in Bleomycin-Induced Mouse Model 110
Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation 109
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 108
MALDI-MS imaging in glomerular kidney diseases: from diagnostics to precision medicine? 108
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 106
Identification of aberrant serum IgG glycoforms in Idiopathic membranous nephropathy 106
Progress in clinical applications for the MALDI-Imaging analysis of thyroid biopsies: evaluation of proteomic stability in preservative solutions 103
Feasibility of MALDI-MSI-Based Proteomics Using Bouin-Fixed Pathology Samples: Untapping the Goldmine of Nephropathology Archives 102
Untargeted mass spectrometry approach to study SARS-CoV-2 proteins and characterize human plasma and saliva proteome in COVID-19 patients. 101
Generation of a spectral library for DIA proteomics analysis and application to serum samples using TIMS-TOF MS/MS 101
Plasma proteome investigation of COVID-19 patients with different outcomes through an untargeted label-free LC-MS/MS approach. 101
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 100
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 100
Customization of LC-MS-based proteomic workflows for biological studies in the clinical field 97
Method for the in vitro diagnosis of thyroid diseases 96
Towards a standardised protocol for proteomic analysis of thyroid fine-needle-aspiration biopsies by MALDI-MSI: Management of haemoglobin interference 95
Towards the Definition of the Molecular Hallmarks of Idiopathic Membranous Nephropathy in Serum Proteome: A DIA-PASEF Approach 92
DIA-PASEF mass spectrometry as a tailored proteomic approach to explore Idiopathic Membranous Nephropathy 92
Tri-modal MALDI-MS imaging of lipids, N-Glycans, and proteins on a single tissue section 89
New insights in lipids MALDI MS imaging in FFPE tissue: Antigen retrieval and its effect on positive ion species 86
New frontiers in Pathology: MALDI-MS Imaging for diagnosis of thyroid fine needle aspiration biopsies 85
Automated radiosynthesis and preclinical evaluation of two new PSMA-617 derivatives radiolabelled via [18F]AlF2+ method 83
Tri-modal MALDI-MS imaging on the same tissue section: deeper molecular insights of disease 83
Tri-modal MALDI-MS Imaging: new frontiers in diagnostics 83
Proteomic investigation of therapy induced senescence in cancer cells by a DIA-PASEF mass spectrometry approach 81
Totale 18.451
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.944
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.944
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020473 0 0 0 0 0 0 0 0 0 202 195 76
2020/20212.733 122 148 294 286 220 225 329 292 205 224 154 234
2021/20221.539 145 146 134 196 79 127 54 96 60 123 149 230
2022/20232.911 299 818 282 322 148 416 38 183 191 35 94 85
2023/20242.325 68 67 106 173 249 652 481 56 144 44 53 232
2024/20253.968 222 473 345 220 481 215 318 222 558 914 0 0
Totale 19.324